Search Login Register
eliprodil
Summary
25
relevant articles (4 outcomes,
9 trials/studies)
found for this Bio-Agent
Description:
cerebral anti-ischemic agents; NMDA receptor antagonist; structure given in first source
Also Known As:
(4-chlorophenyl)-4-((4-fluorophenyl)methyl)-1-piperidineethanol; SL 82-0715; SL 82.0715; SL-820715; 1-Piperidineethanol, alpha-(4-chlorophenyl)-4-(4-fluorophenyl)-, (+-)-
Key Diseases for which eliprodil is
Relevant
-
Stroke (Strokes)
:
2 outcomes 3 studies in 4 results
-
Parkinson Disease (Parkinson's Disease)
:
1 outcome 1 study in 2 results
-
Brain Ischemia (Cerebral Ischemia)
:
1 outcome 1 study in 2 results
-
Infarction
:
1 outcome in 3 results
-
Wounds and Injuries (Trauma)
:
2 studies in 2 results
Show All >>
Drugs Related to eliprodil
-
N-Methylaspartate (NMDA)
-
selfotel
-
eliprodil
-
GV 150526A
-
Reserpine (Serpasil)
-
aptiganel
-
Calcium Channels (Calcium Channel)
-
Dizocilpine Maleate (Dizocilpine)
-
Dextrorphan
-
Glycine (Aminoacetic Acid)
Show All >>
Therapies Related to eliprodil
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.